nirmatrelvir/ritonavir
Brand names: Paxlovid
Paxlovid is a medicine used to treat mild to moderate COVID-19 in adults. It helps prevent severe illness, hospitalization, or death in people at high risk.
Drug Pricing (NADAC)
Brand Price
$69.72/unit
Generic Available
No
PFIZER
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Paxlovid treats mild to moderate COVID-19 in adults.
Common side effects
Change in taste, Diarrhea
Key warnings
Paxlovid can interact with many other medicines, causing serious or life-threatening problems.
How It Works
Paxlovid contains two medicines, nirmatrelvir and ritonavir. Nirmatrelvir stops the virus from multiplying in your body. Ritonavir helps nirmatrelvir stay in your body longer so it can work better.
How to Take It
Start taking Paxlovid as soon as possible after you test positive for COVID-19, and within 5 days of your symptoms starting. Take the tablets by mouth, with or without food. Take Paxlovid at about the same time each day. The usual dose is two 150 mg nirmatrelvir tablets and one 100 mg ritonavir tablet, all taken together twice a day for 5 days.
Pregnancy & Breastfeeding
There is not enough information about nirmatrelvir's safety during pregnancy. Studies on ritonavir in pregnant women have not shown an increased risk of birth defects. Talk to your doctor about the risks and benefits of taking Paxlovid if you are pregnant or breastfeeding.
Missed Dose
If you miss a dose of Paxlovid, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.
Storage
Store Paxlovid at room temperature, between 68°F to 77°F.
Side Effects (from patient reports)
Based on 66,080 FDA adverse event reports.
Serious Warnings
Paxlovid can interact with many other medicines, causing serious or life-threatening problems. Before taking Paxlovid, tell your doctor about all the medicines you take. Your doctor may need to adjust the dose of your other medicines or monitor you more closely.
Known Drug Interactions
HMG-CoA reductase inhibitors lovastatin, simvastatin ↑ lovastatin ↑ simvastatin Co-administration contraindicated due to potential for myopathy including rhabdomyolysis [see Contraindications (4) ] . If treatment with PAXLOVID is considered medically necessary, discontinue use of lovastatin and simvastatin at least 12 hours prior to initiation of PAXLOVID, during the 5 days of PAXLOVID treatment, and for 5 days after completing PAXLOVID.
Mechanism: This medicine stops your body from breaking down simvastatin, which can lead to high levels that cause serious muscle damage.
What to do: Stop taking simvastatin at least 12 hours before starting Paxlovid and do not start it again until 5 days after you finish the treatment.
HMG-CoA reductase inhibitors lovastatin, simvastatin ↑ lovastatin ↑ simvastatin Co-administration contraindicated due to potential for myopathy including rhabdomyolysis [see Contraindications (4) ] . If treatment with PAXLOVID is considered medically necessary, discontinue use of lovastatin and simvastatin at least 12 hours prior to initiation of PAXLOVID, during the 5 days of PAXLOVID treatment, and for 5 days after completing PAXLOVID.
Mechanism: This medicine blocks the way your body processes lovastatin, which can cause the drug to reach dangerous levels and hurt your muscles.
What to do: You should stop taking lovastatin 12 hours before starting Paxlovid and wait 5 days after finishing Paxlovid before taking it again.
Pulmonary hypertension agents (PDE5 inhibitors) sildenafil (Revatio ® ) ↑ sildenafil Co-administration of sildenafil with PAXLOVID is contraindicated for use in pulmonary hypertension due to the potential for sildenafil associated adverse events, including visual abnormalities hypotension, prolonged erection, and syncope [see Contraindications (4) ] . sildenafil, tadalafil, vardenafil ↑ sildenafil ↑ tadalafil ↑ vardenafil Dosage adjustment is recommended for use of sildenafil, tadalafil or vardenafil with PAXLOVID when used for erectile dysfunction.
Mechanism: This combination makes sildenafil stay in your body longer and at higher levels, which can cause your blood pressure to drop too low.
What to do: Avoid this combination if you take sildenafil for high blood pressure in the lungs, or talk to your doctor about a dose change if using it for erectile dysfunction.
Anticonvulsants carbamazepine , phenobarbital, primidone, phenytoin ↓ nirmatrelvir/ritonavir Co-administration contraindicated due to potential loss of virologic response and possible resistance [see Contraindications (4) ] .
Mechanism: Carbamazepine makes your body get rid of the antiviral medicine too quickly, which prevents it from working against the virus.
What to do: Do not take these medicines together because the antiviral treatment will not be able to fight the infection properly.
Antimycobacterial rifampin, rifapentine ↓ nirmatrelvir/ritonavir Co-administration contraindicated due to potential loss of virologic response and possible resistance.
Mechanism: Rifampin causes the body to break down nirmatrelvir/ritonavir too quickly, which lowers the amount of medicine in your blood. This can make the treatment less effective and may lead to the virus becoming resistant.
What to do: Do not take these two medications together.
Common Questions
How long do I take Paxlovid?
Can I take Paxlovid if I have kidney problems?
Can I take Paxlovid if I have liver problems?
What should I do if I feel sick while taking Paxlovid?
Can Paxlovid prevent me from spreading COVID-19 to others?
What if my COVID-19 symptoms get worse after starting Paxlovid?
Can I take Paxlovid to prevent COVID-19?
Will Paxlovid interact with my other medications?
What do the Paxlovid pills look like?
How should I dispose of unused Paxlovid?
What are the common side effects of nirmatrelvir/ritonavir?
Does nirmatrelvir/ritonavir interact with other medications?
What drug class is nirmatrelvir/ritonavir?
Is nirmatrelvir/ritonavir safe during pregnancy?
Related Medications in Antiviral (Protease Inhibitor Combination)
Other drugs grouped near nirmatrelvir/ritonavir — same-class peers and common alternatives.
acyclovir
Zovirax
Acyclovir is an antiviral medicine.
Compare with nirmatrelvir/ritonavir →
albendazole
Albenza
Albendazole is a medicine that fights parasites.
Compare with nirmatrelvir/ritonavir →
amphotericin B
Ambisome, Fungizone
Amphotericin B liposome is an antifungal medicine.
Compare with nirmatrelvir/ritonavir →
anidulafungin
Eraxis
Eraxis is an antifungal medicine.
Compare with nirmatrelvir/ritonavir →
atovaquone/proguanil
Malarone
Malarone is a drug used to prevent and treat malaria.
Compare with nirmatrelvir/ritonavir →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Related Health & Safety Data
🩺 Find a Doctor
Search prescribers for Antiviral (Protease Inhibitor Combination)
🏨 Hospital Quality
CMS hospital ratings, safety scores & patient outcomes
💊 Supplement Data
NIH DSLD — check supplement ingredients & label claims
🍽️ Food Safety Alerts
FDA recalls, inspections & outbreak investigations
⚠️ Product Recalls
FDA, CPSC & NHTSA recall search
💉 Procedure Costs
Medicare procedure pricing for 9,297 procedures
Save on nirmatrelvir/ritonavir
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for nirmatrelvir/ritonavir
The FDA label for nirmatrelvir/ritonavir (sold under brand names such as Paxlovid) classifies it as a prescription-only medication in the Antiviral (Protease Inhibitor Combination) class. Paxlovid treats mild to moderate COVID-19 in adults. Official labeling lists 2 commonly reported side effects, including Change in taste, Diarrhea.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 66,080 voluntary reports. The database also lists 86 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS.
Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: January 5, 2026
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- FDA Orange Book — approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed — NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) — post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm — standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files — federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database — current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages